Relmada Therapeutics, Inc. - Common Stock — 四半期キャッシュフロー (NASDAQ:RLMD) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

総資産 45.82 M27.68 M21.12 M14.88 M94 M235.36 M 負債合計 10.3 M5.24 M5.17 M5.41 M7.49 M16.63 M 純資産合計 35.52 M22.44 M15.95 M9.47 M86.51 M218.73 M 負債および純資産合計 45.82 M27.68 M21.12 M14.88 M94 M235.36 M 有利子負債合計 —————— 純負債 ——————

ニュース

Relmada Therapeutics, Inc. (RLMD) Q1 2026 Earnings Call Transcript

Does Relmada Therapeutics (RLMD) Have the Potential to Rally 75.58% as Wall Street Analysts Expect?

Relmada Therapeutics: 2 New Assets, 2 New 'Blockbusters'? I'd Wait And See (NASDAQ:RLMD)

Relmada Therapeutics, Inc. (RLMD) Q4 2025 Earnings Call Transcript

Mizuho、がん臨床試験の好結果を受けRelmada株の投資判断を維持

Mizuho reiterates Relmada stock rating on positive cancer trial data

RLMD Stock Surges 42% in a Week: Here's What You Should Know

Avago, Lumentum among market cap stock movers on Monday

Tesla and Facebook among market cap stock movers on Monday

Mizuho、膀胱がん試験データを受けてRelmada株の投資判断を据え置き

Mizuho reiterates Relmada stock rating on bladder cancer trial data

Hims & Hersが急騰、ファイザーとAgilent Technologiesは下落